Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases). 1994

J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
Department of Pediatrics, University of California, San Diego, La Jolla 92093.

Experimental conditions essential to a simple, reproducible, quantitative human immunodeficiency virus plasma assay were determined. Five parameters were evaluated: length of culture, reproducibility, assay dilution schema, washing procedures, and anticoagulant usage. The recommended quantitative plasma assay utilizes undiluted citrated plasma cultured with peripheral blood mononuclear cells for 14 days with fivefold dilutions and a medium change on day 1 with no washing.

UI MeSH Term Description Entries
D008828 Microbiological Techniques Techniques used in microbiology. Microbiologic Technic,Microbiologic Technics,Microbiologic Technique,Microbiological Technics,Technic, Microbiologic,Technics, Microbiological,Technique, Microbiologic,Techniques, Microbiologic,Microbiologic Techniques,Microbiological Technic,Microbiological Technique,Technic, Microbiological,Technics, Microbiologic,Technique, Microbiological,Techniques, Microbiological
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019343 Citric Acid A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. Citrate,Anhydrous Citric Acid,Citric Acid Monohydrate,Citric Acid, Anhydrous,Uralyt U

Related Publications

J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
March 1997, NIAID AIDS agenda,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
December 1995, NIAID AIDS agenda,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
March 1992, Obstetrics and gynecology,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
May 1997, The New England journal of medicine,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
January 1999, Antimicrobial agents and chemotherapy,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
July 1999, The Journal of infectious diseases,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
July 1997, The New England journal of medicine,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
June 1997, The New England journal of medicine,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
September 1995, NIAID AIDS agenda,
J L Lathey, and S A Fiscus, and S Rasheed, and J C Kappes, and B P Griffith, and T Elbeik, and S A Spector, and P S Reichelderfer
June 1995, The Journal of infectious diseases,
Copied contents to your clipboard!